Thrive-Montana: A Computerized Cognitive Behavior Therapy (cCBT) Program to Reduce Depression, Anxiety, Suicidal Ideation and Behaviors for Rural Montanans
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Suicidal Ideation
- Sponsor
- Montana State University
- Enrollment
- 725
- Locations
- 1
- Primary Endpoint
- Concise Health Risk Tracking
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
This study evaluates the efficacy of Thrive, a computerized cognitive behavior therapy program, to reduce depression and anxiety symptoms and to reduce suicidal thinking among adults. The first 450 participants will participate in a randomized waitlist controlled trial. The remaining 550 participants will be provided the program immediately upon enrolling
Detailed Description
The efficacy of Thrive has been studied among patient and community populations and has shown to effectively reduce depression and anxiety symptoms among adults with moderate to severe depression symptoms at baseline. This study will examine whether Thrive can also reduce suicidal thinking for persons exhibiting at least moderate depression symptoms. The first phase of the study will implement a randomized waitlist controlled trial. The second phase of the study will examine the effects in a open trial. Outcome assessments will occur at baseline, 4- and 8-weeks (12- and 16-weeks for the waitlist group) with a 6-month follow-up assessment for all participants.
Investigators
Mark B. Schure, Ph.D.
Assistant Professor
Montana State University
Eligibility Criteria
Inclusion Criteria
- •Montana resident
- •18+ years old
- •Have regular access to broadband internet
- •PHQ-9 score greater than 4
Exclusion Criteria
- •No Montana residency
- •\< 18 years old
- •No broadband internet access
- •PHQ-9 score less than 5
Outcomes
Primary Outcomes
Concise Health Risk Tracking
Time Frame: 2 Weeks
Suicidal Thinking; Score range 7 (better) - 35(worse)
Secondary Outcomes
- Connor-Davidson Resilience Scale - Abbreviated Version(1 month)
- Patient Health Questionnaire-9(2 Weeks)
- Generalized Anxiety Disorder Scale-7(2 Weeks)
- Work and Social Adjustment Scale(1 Year)